Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. 1996

T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.

In compensatory hyperplasia after partial hepatectomy or liver cell injury, hepatocyte proliferation is triggered by coordinated actions of growth factor such as hepatocyte growth factor and transforming growth factor-alpha and -beta. Initiation of hepatocyte DNA synthesis is preceded by the activation of the set of early growth response genes mediated by enhanced nuclear factor-kappa B binding to DNA. Using an experimental model to induce hepatocyte DNA synthesis in vivo by a single dose of a peroxisome proliferator, which does not induce liver cell necrosis (direct hyperplasia), we investigated whether peroxisome proliferator-induced hepatocyte proliferation involved an induction of known growth factors, an activation of early growth response genes, and nuclear factor-kappa B. A single intragastric administration of 250 mg/kg BR931 (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-(N-beta-hydroxyethyl) acetamide) to male wistar rats induced a wave of hepatocyte DNA synthesis starting after 12 hours and peaking at approximately 24 to 36 hours. The response was dose dependent. The treatment also induced the expression of the mRNA for the peroxisomal bifunctional enzyme, one of the peroxisome-related fatty acid beta-oxidation enzymes. Pretreatment of rats with dexamethasone (2 mg/kg) inhibited both hepatocyte DNA synthesis and the induction of the peroxisomal bifunctional enzyme gene. Northern blot analyses of liver RNA during a period preceding the onset of DNA synthesis revealed no induction of hepatocyte growth factor, transforming growth factor-alpha, or tumor necrosis factor-alpha mRNAs. No induction of early growth response genes, liver regeneration factor-1, or c-myc was detected. Furthermore, gel mobility shift assays showed no enhanced nuclear factor-kappa B binding to its DNA consensus sequence after BR931 treatment, whereas control studies demonstrated a distinct increase in binding after partial hepatectomy or lead nitrate treatment. The results suggest that peroxisome-proliferator-induced hepatocyte proliferation may be triggered by signal transduction pathways different from those after partial hepatectomy and that the binding of peroxisome proliferators to their nuclear receptors may play a role in stimulation of DNA synthesis and peroxisome proliferation.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008830 Microbodies Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes. Glycosomes,Glycosome,Microbody
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
February 1999, Drug metabolism reviews,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
March 2000, Mutation research,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
June 2001, Carcinogenesis,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
January 1989, Drug metabolism reviews,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
October 1997, Chemical research in toxicology,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
January 2004, Carcinogenesis,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
August 2006, Biochemical and biophysical research communications,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
July 2008, Journal of gastroenterology and hepatology,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
September 1988, Carcinogenesis,
T Ohmura, and G M Ledda-Columbano, and R Piga, and A Columbano, and J Glemba, and S L Katyal, and J Locker, and H Shinozuka
July 2019, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!